> Concomitant use of PHENYLEPHRINE and ATROPINE may enhance pressor effects and induce tachycardia in some patients. Phenylephri ne may potentiate the cardiovascular depressant effects of some inhalation anesthetic medicinal products. In a pharmacokinetic study evaluating OMIDRIA, systemic exposure to each of PHENYLEPHRINE and KETOROLAC was minimal and transient. Therefore, no int eraction is expected. 
